Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Powers

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2003
Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patientsJohn E Bennett, John Powers, Thomas Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2003
Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosisJohn E Bennett, John Powers, Ben de Pauw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2003
Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groupsJohn E Bennett, Carol Kauffman, Thomas Walsh, et al.
Frontiers in Immunology|November 19, 2019
Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus DiseaseRebecca M Broeckel, Nicole Haese, Takeshi Ando, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 12, 2013
White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degenerationCorey T McMillan, David J Irwin, Brian B Avants, et al.
Leukemia Research|June 11, 2016
Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemiaJulio C Chavez, Miguel Piris-Villaespesa, Samir Dalia, et al.
Neurology|July 5, 2014
Myelin oligodendrocyte basic protein and prognosis in behavioral-variant frontotemporal dementiaDavid J Irwin, Corey T McMillan, EunRan Suh, et al.
Bone Marrow Transplantation|April 20, 2018
Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host diseaseLia Perez, Hugo Fernandez, Pedro Horna, et al.
Scientific Reports|October 11, 2019
Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cellsTessa Knox, Eva Sahakian, Debarati Banik, et al.
Blood Advances|July 9, 2021
A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease preventionLia Perez, Hugo Fernandez, Mohamed Kharfan-Dabaja, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2003
Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patientsJohn E Bennett, John Powers, Thomas Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2003
Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosisJohn E Bennett, John Powers, Ben de Pauw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2003
Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groupsJohn E Bennett, Carol Kauffman, Thomas Walsh, et al.
Frontiers in Immunology|November 19, 2019
Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus DiseaseRebecca M Broeckel, Nicole Haese, Takeshi Ando, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 12, 2013
White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degenerationCorey T McMillan, David J Irwin, Brian B Avants, et al.
Leukemia Research|June 11, 2016
Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemiaJulio C Chavez, Miguel Piris-Villaespesa, Samir Dalia, et al.
Neurology|July 5, 2014
Myelin oligodendrocyte basic protein and prognosis in behavioral-variant frontotemporal dementiaDavid J Irwin, Corey T McMillan, EunRan Suh, et al.
Bone Marrow Transplantation|April 20, 2018
Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host diseaseLia Perez, Hugo Fernandez, Pedro Horna, et al.
Scientific Reports|October 11, 2019
Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cellsTessa Knox, Eva Sahakian, Debarati Banik, et al.
Blood Advances|July 9, 2021
A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease preventionLia Perez, Hugo Fernandez, Mohamed Kharfan-Dabaja, et al.
Pageof 6